[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338118-105":59,"doc-detail-338118-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","lesion-size-may-affect-diagnostic-capabilities-of-mri-guided-ultrasound-fusion-biopsy-and-cognitive-targeted-biopsy-for-clinically-significant-prostate-cancer","Lesion size may affect diagnostic capabilities of MRI-guided ultrasound fusion biopsy and cognitive targeted biopsy for clinically significant prostate cancer","","MRI-guided targeted biopsy (MRGB) is recommended for prostate cancer diagnosis, prompting evaluation of how lesion size influences diagnostic performance. A retrospective single-center study enrolled 74 patients with suspicious MRI lesions undergoing MRI-fusion biopsy (MRFB) or MRI-cognitive biopsy (MRCB) alongside systemic biopsy (SB). MRFB showed higher overall prostate cancer and clinically significant prostate cancer detection, especially for lesions ≤1.3 cm. Logistic regression identified PI-RADS score and biopsy method as significant predictors for positive results.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lesion-size-may-affect-diagnostic-capabilities-of-mri-guided-ultrasound-fusion-biopsy-and-cognitive-targeted-biopsy-for-clinically-significant-prostate-cancer/338118/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lesion-size-may-affect-diagnostic-capabilities-of-mri-guided-ultrasound-fusion-biopsy-and-cognitive-targeted-biopsy-for-clinically-significant-prostate-cancer/338118.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the main goal of this study?","Question",{"text":113,"@type":114},"To analyze the diagnostic efficacy of MRI-guided targeted biopsy versus systemic biopsy and compare diagnostic capabilities between MRI-cognitive biopsy and MRI-fusion biopsy subgroups.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How did MRFB perform compared with MRCB and systemic biopsy (SB)?",{"text":118,"@type":114},"MRFB had a higher prostate cancer detection rate and a significantly higher clinically significant prostate cancer detection rate than both MRCB and SB.",{"name":120,"@type":111,"acceptedAnswer":121},"Why does lesion size matter in the study findings?",{"text":122,"@type":114},"For lesions ≤1.3 cm, MRFB provided better diagnostic value than MRCB for prostate cancer and clinically significant prostate cancer, with higher detection and per-core positive rates.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338118,1790173268,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nLesion size may affect diagnostic capabilities of MRI‑guided ultrasound fusion biopsy and cognitive targeted biopsy for clinically significant prostate cancer  \nI‑Hung Shao1,2,3,6, Fan‑Ting Liao1,6, Chun‑Bi Chang4, Ying‑Hsu Chang2,5,  \nLi‑Jen Wang4, Liang‑Kang Huang1,2, Hung‑Cheng Kan1,2, Po‑Hung Lin1, Kai‑Jie Yu1,2, Cheng‑Keng Chuang1,2, Chun‑Te Wu1,2 & See‑Tong Pang1,2*  \nMRI‑guided targeted biopsy (MRGB) was recommended as part of biopsy paradigm of prostate cancers by current guidelines. This study aimed to analyze the diagnostic efficacy of MRGB and systemic biopsy (SB), and to compare diagnostic capabilities within subgroups of MRGB: MRI‑cognitive biopsy (MRCB) and MRI‑fusion biopsy (MRFB). We retrospectively enrolled patients who underwent MRGB for suspicious malignant lesion(s) identified on MRI in a single tertiary center, sample size was 74 patients. An mpMRI was performed prior to biopsy and reviewed by an experienced radiologist specialized in prostate cancer. Per‑person results of MRGB and each concomitant SB were analyzed as independent biopsies for its positive biopsy rate and positive core percentage. Per‑lesion results of MRFB and MRCB were compared for the detection rate. Variables of interest were analyzed with t‑test, chi‑squared test, and logistic regression analysis. Statistical analyses were performed with IBM Statistical Product and Service Solutions (SPSS), Version 23 (IBM, Armonk, New York). Total of 74 patients fulfilled the inclusion criteria and were enrolled. MRFB had higher PCa detection rate comparing to both MRCB and SB (56.1%, 30.3%, and 33.9% respectively, p value = 0.036); clinically significant prostate cancer (csPCa) detection rate was also significantly higher in MRFB group (43.9%, 24.2%, and 16.9% in each group respectively, p value = 0.011). In per‑lesion analysis, MRCB and MRFB had no significant difference in PCa and csPCa detection rate (41.0% vs. 26.2% and 29.5% vs. 16.7% respectively, p value = 0.090 and 0.103) . In the lesion ≦ 1.3 cm group, MRFB could achieve higher PCa detection rate, comparing to MRCB (36.4% vs. 14.3%, p value = 0.047); there were also higher positive rates for PCa and csPCa per biopsied cores (22.1% vs. 6.8% and 15.6% vs. 2.7%, p value = 0.029 and 0.028, respectively). Further logistic regression of multi‑variate analysis in subgroup of lesion ≦ 1.3 cm revealed that PIRADS score and biopsy method were significant predictors of positive biopsy result for PCa (p value = 0.045 and 0.026, respectively) and for csPCa (p value = 0.043 and 0.025, respectively) . In patients receiving trans‑perineal prostate biopsy, MRFB had higher cancer detection rate than  \nMRCB and SB. In per lesion comparison, MRFB and MRCB had similar diagnostic accuracy. However, in lesions with diameter less than 1.3 cm, MRFB can provided better diagnose value for PCa and csPCa than MRCB.  \n1Division of Urology, Department of Surgery, Linkou Chang Gung Memorial Hospital, 5, Fuxing Street, Guishan District, Taoyuan City, Taiwan. 2College of Medicine, Chang Gung University, Taoyuan, Taiwan. 3Graduate Institute of Clinical Medical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan. 4Department of Medical Imaging and Intervention, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. 5Division of Urology, Department of Surgery, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital, New Taipei City, Taiwan. 6These authors contributed equally: I-Hung Shao and Fan-Ting Liao. * email: [pst64lab@gmail.com](pst64lab@gmail.com)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nKeywords MRI fusion biopsy, Prostate biopsy, Cognitive biopsy, Target biopsy, MRFB  \nAs the 2nd most prevalent male malignancy, prostate cancer (PCa) caused over 30,000 deaths in the United States in 20221. Moreover, PCa was also estimated to have a 12% increment from 2001 to 20352 and about 15","cbCaigLikEqzcz47","https://ap.wps.com/l/cbCaigLikEqzcz47","pdf",1118259,"English","# Methods and study design\n## Participants and biopsy approaches\n## Image review and statistical analysis\n# Diagnostic performance results\n## Overall detection rates\n## Per-lesion comparisons\n## Subgroup analysis by lesion size\n# Predictors of positive biopsy","[{\"question\":\"What was the main goal of this study?\",\"answer\":\"To analyze the diagnostic efficacy of MRI-guided targeted biopsy versus systemic biopsy and compare diagnostic capabilities between MRI-cognitive biopsy and MRI-fusion biopsy subgroups.\"},{\"question\":\"How did MRFB perform compared with MRCB and systemic biopsy (SB)?\",\"answer\":\"MRFB had a higher prostate cancer detection rate and a significantly higher clinically significant prostate cancer detection rate than both MRCB and SB.\"},{\"question\":\"Why does lesion size matter in the study findings?\",\"answer\":\"For lesions ≤1.3 cm, MRFB provided better diagnostic value than MRCB for prostate cancer and clinically significant prostate cancer, with higher detection and per-core positive rates.\"}]","Lesion size may affect diagnostic capabilities of MRI-guided ultrasound fusion biopsy and cognitive targeted biopsy for clinically significant prostate cancer | PDF",1790022002,23,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e54cc7d6744df4ce5a69299e68f7bf8.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec95c85ae4b2c8d5e542d422fe2e40be.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9951394414efd418483227dcc586b850.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d86572c6c304fcecec2847e47b63694f.webp",980,1287]